Nasal anti-CD3 spray reduces traumatic brain injury in mice, a potential breakthrough for TBI treatment. Read now.

TBI occurs when the brain is damaged by an external force, like a nasty tackle or a hard punch (or getting pulled over by ...

In a new study on mice, an experimental antibody treatment reduced the lingering after-effects of head injuries.

Researchers at Mass General Brigham found that a nasal spray delivering anti-CD3 (Foralumab) reduces neuroinflammation, limits central nervous system damage and improves behavioral outcomes in mice ...

A new study suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By studying the effects of the nasal anti-CD3 in a ...

A nasal spray developed to combat neuroinflammation has shown promise in treating traumatic brain injury (TBI) in mouse models. | Neuroscience ...

A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway ...

Lastly, we injected the thiol polymers into mice with traumatic brain injury. Brain scans showed that our polymer not only successfully concentrated in the damaged area of the brain but also ...